← Back to Clinical Trials
Recruiting NCT07069179

NCT07069179 Feasibility of Choose to Move Replacement Ready

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07069179
Status Recruiting
Phase
Sponsor University of British Columbia
Condition Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-07-14
Primary Completion 2028-03

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Choose to Move Replacement Ready

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-07-14 with a primary completion date of 2028-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. Recently, the investigators adapted CTM for the \>14000 people in BC who are on surgical waitlists for total knee replacement or total hip replacement (TKR/THR) for osteoarthritis (OA). The primary goal of this observational study is to learn if the adapted program, Choose to Move Replacement Ready (CTM-RR), is feasible to deliver to people with hip and/or knee osteoarthritis who are on surgical waitlists for TKR/THR. Participants who enrol in CTM-RR will answer online survey questions about the program and about their physical activity, mobility, pain, function, quality of life, willingness to undergo surgery, overall perception of their joint condition, psychosocial health, self-efficacy, social isolation, loneliness, and sedentary time. CTM-RR activity coaches will also answer online survey questions about the program. CTM-RR participants, activity coaches, and referral partners will also participate in interviews about the program.

Eligibility Criteria

Inclusion Criteria: 1. Activity coach hired by the Active Aging Society (activity coaches must speak English to participate in the evaluation); 2. English-speaking older adults (aged \>=50 years) who participate in CTM-RR will be invited to participate in the evaluation 3. Referral partner (People who work in a healthcare setting who refer patients into the program) Exclusion Criteria: 1. non-English speaking activity coach 2. non-English speaking referral partner

Contact & Investigator

Central Contact

Douglas L Race, MSc

✉ douglas.race@ubc.ca

📞 604-875-4111'

Principal Investigator

Heather A. McKay, PhD

PRINCIPAL INVESTIGATOR

University of British Columbia

Frequently Asked Questions

Who can join the NCT07069179 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07069179 currently recruiting?

Yes, NCT07069179 is actively recruiting participants. Contact the research team at douglas.race@ubc.ca for enrollment information.

Where is the NCT07069179 trial being conducted?

This trial is being conducted at Vancouver, Canada.

Who is sponsoring the NCT07069179 clinical trial?

NCT07069179 is sponsored by University of British Columbia. The principal investigator is Heather A. McKay, PhD at University of British Columbia. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology